The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Desvenlafaxine Succinate: A New Serotonin and Norepinephrine Reuptake Inhibitor
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
Yung-Chi, C., & Prusoff, W. H. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90196-2 · Cited by 12,922
Neurotransmitter Transporters: Recent Progress
Amara, S. G., & Kuhar, M. J. (1993) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.16.030193.000445 · Cited by 1,082
Expression cloning of a cocaine-and antidepressant-sensitive human noradrenaline transporter
Pacholczyk, T., Blakely, R. D., & Amara, S. G. (1991) · Nature · doi:10.1038/350350a0 · Cited by 933 · cited 4×
“members of the 12-transmembrane-spanning transporter family that moves monoamines across the cell membrane with high affinity in a sodium-dependent manner (Pacholczyk et al., 1991; Amara and Kuhar, 1993; Uhl and Johnson, 1994).”
InfluentialNeuroanatomy of the pain system and of the pathways that modulate pain
Willis, W. D., & Westlund, K. N. (1997) · Journal of Clinical Neurophysiology · doi:10.1097/00004691-199701000-00002 · Cited by 924
Duloxetine vs. placebo in patients with painful diabetic neuropathy
Goldstein, D. J., Lu, Y., Detke, M. J., Lee, T. C., & Iyengar, S. (2005) · Pain · doi:10.1016/j.pain.2005.03.029 · Cited by 858
Bymaster, F. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00298-6 · Cited by 717
Neurotransmitter Receptor and Transporter Binding Profile of Antidepressants and Their Metabolites
Owens, M. J., Morgan, W. N., Plott, S. J., & Nemeroff, C. B. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37161-7 · Cited by 676
Arnold, L. M., Lu, Y., Crofford, L. J., Wohlreich, M., Detke, M. J., Iyengar, S., & Goldstein, D. J. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20485 · Cited by 624 · cited 1×
“Compounds with dual-acting 5-HT and NE monoamine transporter inhibition have been shown to have multiply utilities (Sayar et al., 2003; Schober and Ansani, 2003; Stearns et al., 2003; Arnold et al., 2004; Iyengar et al., 2004; Ladd et al., 2005; Mariappan et al., 2005).”
Stearns, V., Beebe, K. L., Iyengar, M., & Dube, E. (2003) · JAMA · doi:10.1001/jama.289.21.2827 · Cited by 496
Stahl, S. M., Grady, M. M., Moret, C., & Briley, M. (2005) · CNS Spectrums · doi:10.1017/s1092852900019726 · Cited by 458
Muth, E. A., Haskins, J. T., Moyer, J. A., Husbands, G. E. M., Nielsen, S. T., & Sigg, E. B. (1986) · Biochemical Pharmacology · doi:10.1016/0006-2952(86)90769-0 · Cited by 374
Chaput, Y., de Montigny, C., & Blier, P. (1986) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00500007 · Cited by 323
Iyengar, S., Webster, A. A., Hemrick-Luecke, S. K., Xu, J. Y., & Simmons, R. M. A. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.070656 · Cited by 291
Kreiss, D. S., & Lucki, I. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10650-2 · Cited by 277
Le Poul, E., Laaris, N., Doucet, E., Laporte, A.-M., Hamon, M., & Lanfumey, L. (1995) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00176767 · Cited by 257
Serotonin in Pain and Analgesia: Actions in the Periphery
Sommer, C. (2004) · Molecular Neurobiology · doi:10.1385/mn:30:2:117 · Cited by 256
Biogenic amine transporters: regulation in flux
Blakely, R. D., & Bauman, A. L. (2000) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00088-x · Cited by 249
Le Poul, E., Boni, C., Hanoun, N., Laporte, A.-M., Laaris, N., Chauveau, J., Hamon, M., & Lanfumey, L. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00088-x · Cited by 241
Venlafaxine treatment of fibromyalgia
Sayar, K., Aksu, G., Ak, I., & Tosun, M. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1d112 · Cited by 157 · cited 1×
“Compounds with dual-acting 5-HT and NE monoamine transporter inhibition have been shown to have multiply utilities (Sayar et al., 2003; Schober and Ansani, 2003; Stearns et al., 2003; Arnold et al., 2004; Iyengar et al., 2004; Ladd et al., 2005; Mariappan et al., 2005).”
Pristupa, Z. B., Wilson, J. M., Hoffman, B. J., Kish, S. J., & Niznik, H. B. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09894-3 · Cited by 153
Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults
Mariappan, P., Alhasso, A. A., Grant, A., & N'Dow, J. M. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004742.pub2 · Cited by 141
Neurotransmitter Transporters: Three Important Gene Families for Neuronal Function
Uhl, G. R., & Johnson, P. S. (1994) · Journal of Experimental Biology · doi:10.1242/jeb.196.1.229 · Cited by 125
Beyer, C. E., Boikess, S., Luo, B., & Dawson, L. A. (2002) · Journal of Psychopharmacology · doi:10.1177/026988110201600403 · Cited by 114
Self-citationJolas, T., Haj‐Dahmane, S., Kidd, E. J., Langlois, X., Lanfumey, L., Fattaccini, C., Vantalon, V., Laporte, A., Adrien, J., & GOZLAN, H. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38637-4 · Cited by 107
Ladd, C. O., Newport, D. J., Ragan, K., Loughhead, A. M., & Stowe, Z. N. (2005) · Depression and Anxiety · doi:10.1002/da.20085 · Cited by 93
Prasad, P. D., Hoffmans, B. J., Moe, A. J., Smith, C. H., Leibach, F. H., & Ganapathy, V. (1996) · Placenta · doi:10.1016/s0143-4004(96)90039-9 · Cited by 59
Jayanthi, L. D., Ramamoorthy, S., Papapetropoulos, A., Catravas, J. D., Leibach, F. H., & Ganapathy, V. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.29.17189 · Cited by 54
Kirwin, J. L., & Gören, J. L. (2005) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.25.3.396.61600 · Cited by 42
Kaneko, Y. S., Mori, K., Nakashima, A., Sawada, M., Nagatsu, I., & Ota, A. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03209.x · Cited by 33
Effects of central and peripheral depletion of serotonergic system on carrageenan-induced paw oedema
Maleki, N., Nayebi, A. M., & Garjani, A. (2005) · International Immunopharmacology · doi:10.1016/j.intimp.2005.05.012 · Cited by 28
Venlafaxine Hydrochloride for the Treatment of Hot Flashes
Schober, C. E., & Ansani, N. T. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1c483 · Cited by 15
Cited by
Diabetic Peripheral Neuropathy: Epidemiology, Diagnosis, and Pharmacotherapy
Iqbal, Z., Azmi, S., Yadav, R., Ferdousi, M., Kumar, M., Cuthbertson, D. J., Lim, J., Malik, R. A., & Alam, U. (2018) · Clinical Therapeutics · doi:10.1016/j.clinthera.2018.04.001 · Cited by 487
“in patients with painful DPN.(114,173) In a Phase III multicenter, randomized placebo-controlled trial (n = 412), graduated doses of 200 and 400 mg/d desvenlafaxine were found to be effective in relieving pain and improving activity.”
BackgroundSperoff, L., Gass, M., Constantine, G., & Olivier, S. (2008) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000297371.89129.b3 · Cited by 331
Xue, W., Yang, F., Wang, P., Zheng, G., Chen, Y., Yao, X., & Zhu, F. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00490 · Cited by 288
The solute carrier 6 family of transporters
Bröer, S., & Gether, U. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01975.x · Cited by 269
Auclair, A. L., Martel, J. C., Assié, M. B., Bardin, L., Heusler, P., Cussac, D., Marien, M., Newman-Tancredi, A., O'Connor, J. A., & Depoortère, R. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.02.024 · Cited by 263
Metadata
- Authors
- Deecher, D. C., Beyer, C. E., Johnston, G., Bray, J., Shah, S., Abou-Gharbia, M., & Andree, T. H.
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 2006-08
- Volume
- 318
- Issue
- 2
- Pages
- 657-665
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W2115031069
- Cited by
- 381
- References
- 32
- FWCI
- 10.38
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.